NCT00293696View on ClinicalTrials.gov

Casodex/Zoladex Biomarkers in Localised Prostate Cancer

PHASE4CompletedINTERVENTIONAL

Enrollment

30

Participants

Timeline

Start Date

October 31, 2004

Study Completion Date

November 30, 2006

Conditions

Prostate Cancer

Interventions

DRUG

bicalutamide (Casodex), goserelin (Zoladex)

Trial Locations (1)

33521

TUCH, Tampere

All Listed Sponsors

lead

Tampere University

OTHER

NCT00293696 - Casodex/Zoladex Biomarkers in Localised Prostate Cancer | Biotech Hunter | Biotech Hunter